About Immunis.AI
Immunis.AI is a company based in Royal Oak (United States) founded in 2012.. Immunis.AI has raised $22.2 million across 2 funding rounds from investors including Savitr Capital. Immunis.AI operates in a competitive market with competitors including Mirvie, MDxHealth, OncoCyte, Epic Sciences and Miroculus, among others.
- Headquarter Royal Oak, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$22.2 M (USD)
in 2 rounds
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Immunis.AI
Immunis.AI has successfully raised a total of $22.2M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(11 Sep 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2021 | Amount | Series C - Immunis.AI | Valuation | Savitr Capital |
|
| Sep, 2019 | Amount | Series B - Immunis.AI | Valuation | Savitr Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Immunis.AI
Immunis.AI has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Savitr Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Savitr Capital is focused on direct capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Immunis.AI
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Immunis.AI
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Immunis.Ai Comparisons
Competitors of Immunis.AI
Immunis.AI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mirvie, MDxHealth, OncoCyte, Epic Sciences and Miroculus, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
|
| domain | founded_year | HQ Location |
Epigenetic tests for personalized cancer assessment and treatment.
|
|
| domain | founded_year | HQ Location |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive tests for detecting circulating tumor cells are provided.
|
|
| domain | founded_year | HQ Location |
MicroRNA profiling platform is developed to detect genes in samples.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic products for prostate cancer assessment are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Immunis.AI
When was Immunis.AI founded?
Immunis.AI was founded in 2012 and raised its 1st funding round 7 years after it was founded.
Where is Immunis.AI located?
Immunis.AI is headquartered in Royal Oak, United States. It is registered at Royal Oak, Michigan, United States.
Who is the current CEO of Immunis.AI?
Christopher Thibodeau is the current CEO of Immunis.AI.
Is Immunis.AI a funded company?
Immunis.AI is a funded company, having raised a total of $22.2M across 2 funding rounds to date. The company's 1st funding round was a Series B of $22.2M, raised on Sep 11, 2019.
What does Immunis.AI do?
Immunis.AI was founded in 2012 and is based in Royal Oak, United States, within the biotechnology sector focused on oncology diagnostics. A patented platform known as intelligentia is utilized to combine machine learning with disease-specific algorithms. Real-time surveillance of gene expression in monocytes and lymphocytes from patient samples is enabled, allowing detection of immune-response signal changes triggered by threats like cancer. Operations center on RNA expression analysis for early identification.
Who are the top competitors of Immunis.AI?
Who are Immunis.AI's investors?
Immunis.AI has 1 investor. Key investors include Savitr Capital.